Disease | prostate cancer |
Phenotype | C0020619|hypogonadism |
Sentences | 4 |
PubMedID- 26540339 | : aging, hypogonadism, and pharmacological treatment of prostate cancer) is increasing [29,30]. |
PubMedID- 24741451 | For example, kallmann and klinefelter syndromes, pituitary and hypothalamic tumors, and androgen deprivation therapy for prostate cancer can all lead to hypogonadism, and are associated with low bone mineral density (bmd) and an increased risk of fractures [7,8,9,10]. |
PubMedID- 22110984 | It has been also shown in a small trial that hypogonadism in males with prostate cancer results in a rise in the augmentation of central arterial pressure, suggesting large artery stiffening. |
PubMedID- 21276398 | In men with iatrogenic hypogonadism due to prostate cancer, the risk of vertebral fractures is decreased by 62%. |
Page: 1